2007•Zhongguo shiyong fuke yu chanke zazhiRequires access

A diagnostic and monitoring value of lysophosphatidic acid for ovarian epithelial cancer

Li Shi

Open publisher page 0 citations

Abstract

Objective To investigate the value of lysophosphatidic acid for diagnosis and monitoring of ovarian epithelial cancer.Methods We measured LPA and CA125 in plasma and in ascitic fluid from ovarian epithelial cancer(n=40) with preoperative and postoperative and benign ovarian neoplasm(n=20) from 2005-04 to 2005-10 in the Fourth Hospital of Hebei Medical University.Results Patients with ovarian epithelial cancer had significantly higher plasma and ascitic fluid LPA levels compared with the benign control group(P0.01 P0.01),and postoperative LPA levels were significantly lower than preoperative levels(P0.01).The diagnostic sensitivity and specificity of plasma LPA for stage Ⅰovarian epithelial cancer were 75% and 80%,while CA125 was 50% and 40%.Conclusion LPA levels may be a new biomarker for detecting early-stage ovarian epithelial cancer.LPA levels appear useful as monitoring and prognostic biomarkers of ovarian epithelial cancer.

About this research paper

What this paper is about

Objective To investigate the value of lysophosphatidic acid for diagnosis and monitoring of ovarian epithelial cancer.Methods We measured LPA and CA125 in plasma and in ascitic fluid from ovarian epithelial cancer(n=40) with preoperative and postoperative and benign ovarian neoplasm(n=20) from 2005-04 to 2005-10 in the Fourth Hospital of Hebei Medical University.Results Patients with ovarian epithelial cancer had significantly higher plasma and ascitic fluid LPA levels compared with the benign control group(P0.01 P0.01),and postoperative LPA levels were significantly lower than preoperative levels(P0.01).The diagnostic sensitivity and specificity of plasma LPA for stage Ⅰovarian epithelial cancer were 75% and 80%,while CA125 was 50% and 40%.Conclusion LPA levels may be a new biomarker for detecting early-stage ovarian epithelial cancer.LPA levels appear useful as monitoring and prognostic biomarkers of ovarian epithelial cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the value of lysophosphatidic acid for diagnosis and monitoring of ovarian epithelial cancer.Methods We measured LPA and CA125 in plasma and in ascitic fluid from ovarian epithelial cancer(n=40) with preoperative and postoperative and benign ovarian neoplasm(n=20) from 2005-04 to 2005-10 in the Fourth Hospital of Hebei Medical University.Results Patients with ovarian epithelial cancer had significantly higher plasma and ascitic fluid LPA levels compared with the benign control group(P0.01 P0.01),and postoperative LPA levels were significantly lower than preoperative levels(P0.01).The diagnostic sensitivity and specificity of plasma LPA for stage Ⅰovarian epithelial cancer were 75% and 80%,while CA125 was 50% and 40%.Conclusion LPA levels may be a new biomarker for detecting early-stage ovarian epithelial cancer.LPA levels appear useful as monitoring and prognostic biomarkers of ovarian epithelial cancer.

Key concepts: Lysophosphatidic acid, Ovarian cancer, Epithelial ovarian cancer, Medicine, Stage (stratigraphy), Biomarker, Internal medicine, Cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
A diagnostic and monitoring value of lysophosphatidic acid for ovarian epithelial cancer — Research Paper | ScholarLens